نتائج البحث - "Frank G Holz"

1

Central serous chorioretinopathy: Towards an evidence-based treatment guideline

المساهمون: van Rijssen, Thomas J, van Dijk, Elon H C, Yzer, Suzanne, Ohno-Matsui, Kyoko, Keunen, Jan E E, Schlingemann, Reinier O, Sivaprasad, Sobha, Querques, Giuseppe, Downes, Susan M, Fauser, Sascha, Hoyng, Carel B, Piccolino, Felice Cardillo, Chhablani, Jay K, Lai, Timothy Y Y, Lotery, Andrew J, Larsen, Michael, Holz, Frank G, Freund, K Bailey, Yannuzzi, Lawrence A, Boon, Camiel J F

المصدر: Progress in Retinal and Eye Research, 73, 100770
Progress in Retinal and Eye Research, 73
van Rijssen, T J, van Dijk, E H C, Yzer, S, Ohno-Matsui, K, Keunen, J E E, Schlingemann, R O, Sivaprasad, S, Querques, G, Downes, S M, Fauser, S, Hoyng, C B, Piccolino, F C, Chhablani, J K, Lai, T Y Y, Lotery, A J, Larsen, M, Holz, F G, Freund, K B, Yannuzzi, L A & Boon, C J F 2019, ' Central serous chorioretinopathy : Towards an evidence-based treatment guideline ', Progress in Retinal and Eye Research, vol. 73, 100770 . https://doi.org/10.1016/j.preteyeres.2019.07.003
Progress in Retinal and Eye Research, 73, pp. 100770

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Evidence-based practice, Central serous chorioretinopathy, Mineralocorticoid Antagonists, Psychological intervention, Disease, Guideline, Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12], Photodynamic therapy, Retina, 03 medical and health sciences, 0302 clinical medicine, Humans, Medicine, Intensive care medicine, Mineralocorticoid Receptor Antagonists, Evidence-Based Medicine, Laser Coagulation, Photosensitizing Agents, business.industry, Micropulse laser, Mineralocorticoid antagonist, Verteporfin, Sensory Systems, Treatment, Ophthalmology, Serous fluid, 030104 developmental biology, Photochemotherapy, Treatment study, Practice Guidelines as Topic, 030221 ophthalmology & optometry, business, medicine.drug

وصف الملف: text; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5a1d166660769648c8d8572345bd82
https://doi.org/10.1016/j.preteyeres.2019.07.003

View record from ScienceDirect

2

Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study

المؤلفون: Frank G. Holz, Moritz Berger, Peter Charbel Issa, Almut Wingen, Johannes Birtel, Christoph Coch, Philipp Herrmann, Rolf Fimmers, Martin Gliem

المصدر: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 258(2)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, genetic structures, Fundus Oculi, Recombinant Fusion Proteins, Visual Acuity, 03 medical and health sciences, Cellular and Molecular Neuroscience, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Ophthalmology, medicine, Clinical endpoint, Humans, Prospective Studies, Fluorescein Angiography, Pseudoxanthoma Elasticum, Prospective cohort study, Aflibercept, business.industry, Choroid, Retinal, Middle Aged, medicine.disease, Pseudoxanthoma elasticum, Sensory Systems, Choroidal Neovascularization, Angioid streaks, 030104 developmental biology, Choroidal neovascularization, Receptors, Vascular Endothelial Growth Factor, Treatment Outcome, chemistry, Intravitreal Injections, 030221 ophthalmology & optometry, Quality of Life, Female, medicine.symptom, business, Microperimetry, Tomography, Optical Coherence, medicine.drug, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386f4e34aefbf665c1124bee9397be12
https://pubmed.ncbi.nlm.nih.gov/31863395

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

3

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

المصدر: The British Journal of Ophthalmology
Gale, R P, Pearce, I, Eter, N, Ghanchi, F, Holz, F G, Schmitz-Valckenberg, S, Balaskas, K, Burton, B J L, Downes, S M, Eleftheriadis, H, George, S, Gilmour, D, Hamilton, R, Lotery, A J, Patel, N, Prakash, P, Santiago, C, Thomas, S, Varma, D, Walters, G, Williams, M, Wolf, A, Zakri, R H, Igwe, F & Ayan, F 2020, ' Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study ', British Journal of Ophthalmology, vol. 104, no. 4, pp. 493-499 . https://doi.org/10.1136/bjophthalmol-2019-314251

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, Visual acuity, genetic structures, Visual Acuity, degeneration, Angiogenesis Inhibitors, neovascularisation, 0302 clinical medicine, Pro re nata, Germany, Clinical endpoint, Single-Blind Method, Prospective Studies, Fluorescein Angiography, Prospective cohort study, Aflibercept, Aged, 80 and over, education.field_of_study, Drug Substitution, imaging, clinical trial, Middle Aged, Clinical Science, Sensory Systems, Intravitreal Injections, Female, medicine.symptom, medicine.drug, medicine.medical_specialty, Recombinant Fusion Proteins, Population, Retina, 03 medical and health sciences, Cellular and Molecular Neuroscience, SDG 3 - Good Health and Well-being, Ophthalmology, Ranibizumab, medicine, Humans, macula, education, Aged, business.industry, Macular degeneration, medicine.disease, Choroidal Neovascularization, United Kingdom, Receptors, Vascular Endothelial Growth Factor, 030221 ophthalmology & optometry, Wet Macular Degeneration, business, 030217 neurology & neurosurgery, Follow-Up Studies